Table 1 Clinical characteristics of the two groups of participants
From: Role of plasma neuropeptide Y in acute myocardial infarction: a case-control study
Index | AMI group(n = 128) | Control group(n = 62) | P |
|---|---|---|---|
Demographics | |||
Smoking | 71(55.5%) | 20(32.3%) | 0.009 |
Men | 87(68.0%) | 40(64.5%) | 0.636 |
Age | 54.34 ± 8.39 | 51.77 ± 8.50 | 0.05 |
BMI, kg/m² | 25.60 ± 1.24 | 24.58 ± 1.16 | 0.18 |
Clinical features | |||
mBP/mmHg | 96.74 ± 13.86 | 90.94 ± 13.76 | 0.07 |
FPG/mmol.L− 1 | 6.03 ± 1.71 | 5.35 ± 0.89 | 0.04 |
HbA1c/% | 6.22 ± 1.13 | 5.99 ± 0.68 | 0.086 |
Cre/umol.L− 1 | 81.68 ± 19.08 | 72.62 ± 18.72 | 0.184 |
TC/mmol.L− 1 | 4.91 ± 0.91 | 4.75 ± 1.26 | 0.05 |
TG/mmol.L− 1 | 1.70 ± 1.18 | 1.34 ± 1.49 | 0.100 |
LDLC/mmol.L− 1 | 3.09 ± 0.75 | 2.81 ± 1.00 | 0.043 |
Clinical presentation | |||
NSTEMI | 60(46.9%) | ||
STEMI | 68(53.1%) | ||
SYNTAX score | |||
≤ 22 | 46(35.9%) | ||
23 = 32 | 46(35.9%) | ||
≥ 33 | 36(28.1%) | ||
Culprit vessel | |||
Left anterior descending artery | 77(60.2%) | ||
Left circumflex artery | 10(7.8%) | ||
Right coronary artery | 41(32.0%) | ||
Medication history (before sampling) | |||
Antiplatelet | 58(45.3%) | 16(25.8%) | |
Beta-blocker | 54(42.2%) | 24(38.7%) | |
Statin drugs | 60(46.9%) | 21(33.9%) |